How should I manage the side effects of intravesical Bacillus Calmette-Guérin (BCG) therapy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 21, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Management of Intravesical BCG Side Effects

For mild cystitis symptoms, treat with bladder irritation relief agents (phenazopyridine), anticholinergics, and NSAIDs, continuing BCG when symptoms resolve within a few days; if symptoms persist beyond 48 hours or worsen, postpone instillation, obtain urine culture, and start empirical quinolone antibiotics. 1

Algorithmic Approach by Side Effect Type

Local Side Effects

Cystitis Symptoms (Most Common)

  • Mild symptoms:

    • Administer phenazopyridine, anticholinergics, and NSAIDs
    • Continue instillations when symptoms improve within days 1
  • Persistent symptoms (>48 hours) or worsening:

    1. Postpone instillation or reduce BCG dose
    2. Perform urine culture
    3. Start empirical oral quinolone antibiotics 1
  • If symptoms persist after antibiotics:

    • Positive culture: Adjust antibiotics per sensitivity
    • Negative culture: Intravesical quinolone + anti-inflammatory/analgesic instillations daily for 5 days (repeat if necessary) 1

Hematuria

  • Perform urine culture to exclude hemorrhagic cystitis
  • Resume instillation when urine clears
  • If persistent: Perform cystoscopy to evaluate for tumor
  • Macrohematuria: Indwelling catheter with continuous bladder irrigation; endoscopic hemostasis if necessary 1

Granulomatous Prostatitis

  • Symptomatic:
    • Perform urine culture
    • Suspend instillations
    • Administer isoniazid + rifampicin orally for 3 months, plus quinolones and corticosteroids 1
  • Asymptomatic: No treatment required 1

Epididymo-orchitis

  1. Perform urine culture
  2. Cease intravesical therapy
  3. Administer quinolone antibiotics or anti-tuberculous drugs
  4. If persistent: Add hormone therapy
  5. If abscess develops: Incision and drainage
  6. Last resort: Orchiectomy 1

Urethral Stricture

  • Postpone instillation
  • Perform spasmolytic treatment
  • Avoid drug flow into urethra during future instillations
  • If persistent/worsening: Urethral dilatation or urethrotomy 1

Bladder Contracture

  • Postpone instillation
  • Use lidocaine for sedation/analgesia
  • Perform bladder enlargement if necessary 1

Systemic Side Effects

General Malaise/Fever

  • Mild symptoms resolving within 48 hours: Observation only 1

  • Fever >38.5°C for >48 hours:

    1. Suspend BCG instillations
    2. Perform urine culture for bacteria and acid-fast bacilli
    3. Treat with broad-spectrum antibiotics + anti-tuberculosis drugs
    4. Consult relevant specialists 1

BCG Sepsis (Life-Threatening)

This is a medical emergency requiring immediate action:

  1. Stop BCG immediately
  2. Transfer to ICU
  3. Perform urine culture for bacteria and acid-fast bacilli
  4. Administer broad-spectrum antibiotics + anti-tuberculosis drugs + corticosteroids
  5. For severe cases without renal failure: Consider oral cycloserine with blood concentration monitoring
  6. BCG instillation permanently contraindicated after recovery 1

Allergic Reactions

  1. Postpone or suspend instillations if symptoms worsen
  2. Administer antihistamines and anti-inflammatory agents
  3. Increase antibiotic dosage or add anti-tuberculosis drugs if necessary 1

Rare Autoimmune Reactions

(Arthritis, hepatitis, pneumonia, bone marrow suppression)

  • Treat with NSAIDs, corticosteroids, quinolones, or anti-tuberculosis drugs 1

Critical Timing Considerations

BCG must be started at least 2 weeks after TURBT to prevent sepsis risk 1. This is an absolute contraindication that must be strictly followed.

Evidence on Prophylactic Quinolones

While the 2022 guideline recommends cautious use of quinolones for BCG-related side effects 2, the NCCN 2026 guideline notes that symptom management with single-dose, short-term quinolones and/or anticholinergics have been reported to reduce adverse events 3. Recent research from 2025 supports that clinicians can prevent treatment discontinuation through quinolone use in high-risk patients 4.

Common Pitfalls to Avoid

  • Never administer BCG with visible hematuria, after traumatic catheterization, or with symptomatic UTI 2
  • Do not use pyrazinamide for systemic BCG infections—BCG strains are resistant 5
  • Do not delay treatment of fever >38.5°C lasting >48 hours—this may progress to sepsis
  • Recognize that dose reduction may be necessary but should be balanced against efficacy 3

The key to successful BCG therapy is early recognition and appropriate escalation of treatment based on symptom severity and duration, while maintaining the most complete BCG course possible to optimize oncologic outcomes.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.